CHKA and malignant colon neoplasm: The pooled results exhibited that CKI combined with chemotherapeutic drugs could be a preferable treatment option for advanced colon cancer patients, because efficacy (OR = 1.48, 95% CI: 1.21–1.80) benefits had been significantly improved.